PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.500
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
1.580
+0.080 (5.33%)
After-hours: Dec 20, 2024, 4:10 PM EST
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $77.62 million as of December 20, 2024. Its market cap has decreased by -34.03% in one year.
Market Cap
77.62M
Enterprise Value
-107.05M
1-Year Change
-34.03%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $77.62M, a decrease of -95.19%. That is a compound annual growth rate of -51.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 77.62M | -51.06% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 23andMe Holding Co. | 79.96M |
| Context Therapeutics | 79.87M |
| So-Young International | 79.71M |
| Galectin Therapeutics | 79.08M |
| Adlai Nortye | 78.97M |
| Quince Therapeutics | 77.00M |
| Theratechnologies | 76.87M |
| Ikena Oncology | 76.73M |